Showing results (151-160 of 294) with videos related to
Sort By:
Pageof 30
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
Radiotherapy for unresectable sinonasal cancers: dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapyEster Orlandi, Tommaso Giandini, Eva Iannacone, et al.Journal of Cancer Research and Clinical Oncology|July 4, 2020
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancerMauro Guglielmo, Patricia Di Pede, Salvatore Alfieri, et al.Cancers|November 14, 2023
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab TreatmentMarco Carlo Merlano, Matteo Paccagnella, Nerina Denaro, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 3, 2025
Challenges in pathological diagnosis of rare head and neck cancers: National survey and retrospective studyDaria Maria Filippini, Francesca Carosi, Giulia Querzoli, et al.Head & Neck|November 18, 2018
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trialsPaolo Bossi, Rosalba Miceli, Marco Benasso, et al.International Journal of Radiation Oncology, Biology, Physics|September 21, 2007
Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring systemMauro Palazzi, Stefano Tomatis, Ester Orlandi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018
Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1Denis Soulières, Lisa Licitra, Ricard Mesía, et al.Head & Neck|January 1, 2005
Which classification for ethmoid malignant tumors involving the anterior skull base?Giulio Cantù, Carlo L Solero, Rosalba Miceli, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 26, 2020
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancerKenneth Emancipator, Lingkang Huang, Deepti Aurora-Garg, et al.Tumori|May 2, 2018
Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancersCarlo Resteghini, Federica Perrone, Rosalba Miceli, et al.Pageof 30